id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-2379-0004,FDA,FDA-2016-E-2379,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T18:16:55Z,,0,0,0900006482438391
FDA-2016-E-2379-0003,FDA,FDA-2016-E-2379,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-08-29T04:00:00Z,2016,8,2016-08-29T04:00:00Z,,2016-08-29T14:49:52Z,,0,0,09000064821a8f90
FDA-2016-E-2379-0002,FDA,FDA-2016-E-2379,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-08-03T04:00:00Z,2016,8,2016-08-03T04:00:00Z,,2016-08-03T15:54:19Z,,0,0,090000648214fef2
FDA-2016-E-2379-0001,FDA,FDA-2016-E-2379,"Patent Extension Application from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (on behalf of CSL Behring GmbH)",Other,Letter(s),2016-08-02T04:00:00Z,2016,8,2016-08-02T04:00:00Z,,2016-08-03T01:20:08Z,,0,0,090000648214feee